












2016; publisheThe Prognostic Significance of Different
Definitions for Angiosome-Targeted Lower
Limb RevascularizationKristyna Spillerova,1 Fausto Biancari,2 Nicla Settembre,1 Anders Alb€ack,1
and Maarit Venermo,1 Helsinki, and Oulu, FinlandBackground: The definition of angiosome-targeted revascularization is confusing, especially
when a tissue lesion affects several angiosomes. Two different definitions of direct revascular-
ization exist in the literature. The study aim was (1) to compare the 2 definitions of direct revas-
cularization in patients with foot lesions involving more than one angiosome and (2) to evaluate
which definition better predicts clinical outcome.
Methods: This study cohort comprises 658 patients with Rutherford 5e6 foot lesions who un-
derwent infrapopliteal endovascular or surgical revascularization between January 2010 and
July 2013. We compared the 2 angiosome-targeted definitions using multivariate analysis; the
impact of each angiosome-targeted definition was adjusted for a propensity score obtained by
means of nonparsimonious logistic regression.
Results: Direct revascularization according to definition A was performed in 367 cases (55.8%)
versus 198 cases (30.1%) with definition B. The propensity-score-adjusted analysis showed that
definition A of direct revascularization was associated with significantly better wound healing
(P < 0.044, hazard ratio [HR] 1.291) and lower amputation rates (P < 0.047, HR 0.706),
whereas definition B was associated only with significantly better wound healing (P < 0.029,
HR 1.321). The prognostic ability of direct revascularization according to definition A was
confirmed in a Cox proportional hazard analysis.
Conclusions: Definition A of direct revascularization was associated with a significantly higher
wound healing and leg salvage rate than indirect revascularization in both series. Therefore, it
seems that, if the wound spreads over several angiosomes in the forefoot or heel, any angio-
some involved in the wound can be targeted.INTRODUCTION
Recently, the angiosome concept has offered a new
perspective on revascularization in patients with
critical limb ischemia (CLI) and tissue loss. Aninterest: None.
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d online: 29 September 2016angiosome was defined by Taylor and Palmer1 as a
three-dimensional block of tissue supplied and
drained by specific, ‘‘angiosomal vessels.’’
Attinger et al.2 presented that the foot consist of 6
angiosome regions, each supplied by one of the
crural arteries and its terminal branches. The
concept of angiosome-targeted (direct) revasculari-
zation is based on this division. Direct revasculariza-
tion (DR) refers to the selective revascularization of
the specific artery feeding the angiosome that is
affected by an ulcer. If angiosome-targeted revascu-
larization is successful, direct flow from the abdom-
inal aorta to the angiosomal vessel is achieved.3,4
Two meta-analyses, including a total of 15
studies, have reported that wound healing and
limb salvage, especially in patients with diabetes,
are better after DR.5,6 However, the definition of183
184 Spillerova et al. Annals of Vascular SurgeryDR is not clear and, in many of the studies, the defi-
nition is lacking altogether. Most of the studies
accept an approach as DR if the angiosome with
the affected surface is revascularized, with the
exception of the forefoot and heel where any angio-
some involved in the wound can be targeted.3,4,7e11
This exception, however, does not apply to a new
definition suggested by Alexandrescu12 in his
book, Angiosomes Application in Critical Limb Ischemia
in Search for Relevance. DR for wounds located in the
forefoot and heel is defined as a procedure on the
posterior tibial artery only. Furthermore, the defini-
tion of the angiosome-guided approach in cases
where the wound spans several angiosome regions
is scarce.
As recently reported, the wound is located across
more than one angiosome in themajority of patients
with CLI and tissue lesions.13 There is a high pre-
dominance of tissue loss located in the toes, meta-
tarsal heads, and the heel.14 Therefore, we aimed
to investigate which of the 2 existing definitions of
DRs predicts better wound healing and leg salvage.MATERIALS AND METHODS
The study plan was accepted by the Ethical Commit-
tee of the Helsinki University Central Hospital.PatientsThis retrospective study included 774 consecutive
patients with CLI and tissue loss (Rutherford 5e6),
who underwent infrapopliteal endovascular or sur-
gical revascularization in our institution between
January 2010 and June 2013. Only patients with a
foot lesion spreading over several angiosomes or
located in more than one angiosome were included.
Exclusion criteria were previous infrainguinal
revascularization and incomplete information on
the status of the foot.DefinitionsAn ischemic foot ulcer was defined as a full-
thickness skin defect distal to the malleolar level
presented for at least 2 weeks with a toe pressure
of<50 mmHg. If toe pressure could not be obtained
for some reason (pain, noncompressible artery, or
necrosis), the transcutaneous partial pressure of ox-
ygenwasmeasured,with a level of<30mmHg indi-
cating an ischemic lesion.
The revascularization techniques in our institution
have been described earlier.3,15 Our policy is to
perform percutaneous transluminal angioplasty
(PTA) as a first-line revascularization in stenoticlesions, short occlusions, and in patients who have
increased risk for bypass surgery or no autologous
vein available. In case of long occlusions in patients
who are fit for surgery and do have autologous vein,
the policy is to do bypass first. Before PTA, all patients
were taking aspirin (100 mg/day). All patients
continued life-long aspirin therapy accompanied
with clopidogrel for 3 months (75 mg/day) after the
procedure. Patients treatedby endovascular approach
first had isolated infrapopliteal lesion in 343 (78.5%)
cases; no stent was used for these crural lesions. For
bypass surgery, the single-segment great saphenous
vein graft (nonreversed, placed under fascia) was
used in 64.3%, spliced vein grafts in 30.3%, compos-
ite vein with prosthesis in 4.1%, and prosthetic graft
in 1.4%. Intraoperative heparin was administered
before graft insertion. The patients received low-
molecular-weightheparin (1mg/kg/day)during their
hospital stay accompanied with life-long aspirin ther-
apy (100 mg/day) unless contraindicated.
In the literature, 2 definitions of DR in the case of
a foot ulcer spreading over the forefoot and heel are
available. Definition A accepts DR if any of the
affected angiosomes are revascularized3,7e11; for
example, if the lesion is located in the tip of the
toes or the toes are amputated due to gangrene, pro-
cedures on either the anterior tibial artery/pedal ar-
tery or the posterior tibial artery/plantar arteries, or
both, are considered angiosome-targeted. While
definition B only accepts the revascularization of
posterior tibial artery/plantar arteries as an
angiosome-targeted procedure12 (Table I).
In cases of a foot ulcer spreading over several
angiosomes in other location than the forefoot or
heel, we adopted the same approach as described
in the study by Iida et al.16,17 DR was defined as a
procedure on the artery supplying the largest sur-
face of the angiosome involved in the lesion. For
example, large necrotic lesion in the dorsum foot
of spreading to the medial foot instep, or lesion
located at the level of lateral malleolus continuing
to dorsum of the foot. In such case, arteria tibialis
anterior ± arteria dorsalis pedis would be the corre-
sponding artery for revascularization.
If the patient suffered from multiple foot ulcers
located in separate angiosomes, all affected angio-
somes had to be revascularized for the intervention
to count as DR.Wound LocationWe adopted the general scheme of angiosomal dis-
tribution3 to evaluate the number of affected angio-
somes. Ever since we started the research on
angiosome concept in 2009, ischemic tissue defect
Table I. Scheme showing which artery needs to be revascularized in cases where the wound spreads over
several angiosomes in the location of the forefoot or heel
Revascularization Definition A Definition B
Direct Indirect Direct IndirectWound location
Forefoot ATA/ADP ± ATP/plantar arteries AF ATP/plantar arteries ATA, AF
Heel AF ± ATP/plantar arteries ATP/ADP ATP/plantar arteries ATA, AF
ADP, arteria dorsalis pedis; AF, arteria fibularis; ATA, arteria tibialis anterior; ATP, arteria tibialis posterior.
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patient’s records. Therefore, the location and
severity of the tissue loss was obtained by reviewing
our clinical notes by 2 observers, a trainee of
vascular surgery with anatomical background and
a vascular surgeon with clinical experience more
than 15 years. In 95 cases, photographs were avail-
able and compared with clinical notes. In many
cases, the tissue defect was severe (gangrene, infec-
tion) and required periprocedural digit amputation
or metatarsal amputation. In such cases, the wound
was immediately affecting 2 or 3 angiosomes,
depending on the amputation level.Wound Healing and Follow-upThe wound care depended on the characteristics of
each lesion: debridement of necrotic tissue, surgical
revision of infected ulcers together with microbial
therapy, and the application of a skin graft in cases
where primary or secondary closure was not
possible.3 A healed wound was defined as complete
epithelialization of the tissue defect by secondary
intent or after any additional local ulcer surgery.
The wound was considered nonhealed if it was still
open at the end of the follow-up.
After revascularization, patients remained under
routine surveillance in the outpatient clinic by a
vascular nurse who carried out a duplex ultrasound
examination of the revascularized artery and fol-
lowed the foot status; a vascular surgeon was con-
sulted if necessary. In the case of PTA, the visits
were scheduled at 1, 3, and 6 months after revascu-
larization, and in the case of a bypass graft at 1, 3, 6,
and 12 months after revascularization. If the duplex
examination of bypass graft showed signs of steno-
sis, the patient underwent control digital subtrac-
tion angiogram (DSA) within 2 weeks; a PTA to
bypass graft was performed in case of confirmed ste-
nosis. If the wound opened after routine duplex sur-
veillance ended, the patient continued visits to the
outpatient clinic until the wound healed. The
follow-up ended and the wound was considered as
nonhealed if the patient underwent a new infrain-
guinal bypass due to failure of primary intervention(endovascular or surgical), new additional PTA of
crural arteries after primary intervention, or a major
amputation due to nonhealing foot ulcer or
occluded bypass graft, or if the patient died.Data CollectionData collection was performed using our prospec-
tively collected database and scrutinizing it retro-
spectively by reviewing patient records as well as
the patient’s imaging files. In patients who under-
went endovascular treatment, DSAs before and after
revascularization were reviewed to evaluate
whether an angiosome-targeted procedure had
been performed, and in patients undergoing surgical
bypass, the preoperative magnetic resonance angio-
grams and DSAs, if available, were reviewed as well.
All patients treated by PTA had on-table DSA right
after revascularization as a control of possible com-
plications (dissection, microembolism).
The patient’s baseline characteristics and opera-
tive data are summarized in Table II.
Estimated glomerular filtration rate (eGFR) was
estimated by the Modification of Diet in Renal Dis-
ease formula (Levey).Outcome MeasuresWe compared the outcome of DR versus indirect
revascularization (IR) using the2 above-described
definitions. The primary outcome measures were
wound healing and leg salvage. Survival was a sec-
ondary outcome end point.Statistical AnalysisStatistical analysis was performed using SPSS
version 22.0 statistical software (IBM SPSS, Inc.,
Chicago, IL). No attempt to replace missing values
was made. Fisher’s exact test, the chi-squared test,
and the ManneWhitney and KaplaneMeier tests
were used for univariable analysis. Multivariate
analysis for assessing the impact of baseline vari-
ables on late outcome was performed using the
Cox proportional hazards method. The impact of
each DR definition was adjusted for a propensity
Table II. Baseline characteristics of patients undergoing lower limb revascularization according to 2
different definitions of direct (angiosome-targeted) revascularization
Variable









Age 75.5 ± 11.3 73.8 ± 11.1 0.047 75.6 ± 11.0 72.1 ± 11.5 <0.0001
Female 107 (36.8) 139 (37.9) 0.771 181 (39.3) 65 (32.8) 0.113
Smoking habit 41 (14.1) 55 (15.0) 0.746 61 (13.3) 35 (17.7) 0.141
Pulmonary disease 38 (13.1) 37 (10.1) 0.233 58 (12.6) 17 (8.6) 0.136
Atrial fibrillation 94 (32.3) 99 (27.0) 0.136 147 (32.0) 46 (23.2) 0.024
Hypertension 195 (67.0) 220 (59.9) 0.062 293 (63.7) 122 (61.6) 0.612
Estimated glomerular filtration rate 74.9 ± 36.1 76.3 ± 39.2 0.663 74.8 ± 36.4 77.9 ± 41.0 0.360
Dialysis 11 (3.8) 29 (7.9) 0.028 22 (4.8) 18 (9.2) 0.048
Kidney transplantation 4 (1.4) 6 (1.6) 0.786 4 (0.9) 6 (3.0) 0.074
Diabetes 176 (60.5) 233 (63.5) 0.430 280 (60.9) 129 (65.2) 0.299
Coronary artery disease 118 (40.5) 127 (34.6) 0.117 180 (39.1) 65 (32.8) 0.125
Heart failure 39 (13.4) 45 (12.3) 0.663 60 (13.0) 24 (12.1) 0.745
Stroke 44 (15.1) 48 (13.1) 0.453 65 (14.1) 27 (13.6) 0.867
C-reactive protein (mg/dL) 46.3 ± 53.8 47.9 ± 54.2 0.835 49.5 ± 54.4 41.7 ± 52.5 0.004
C-reactive protein >10 mg/dL 197 (67.7) 254 (69.2) 0.678 330 (71.7) 121 (61.1) 0.007
Gangrene 69 (23.7) 124 (33.8) 0.005 138 (30.0) 55 (27.8) 0.566
No. of affected angiosomes 2.3 ± 1.1 2.2 ± 0.7 0.815 2.3 ± 0.9 2.0 ± 0.8 <0.0001
Complete pedal arch 45 (15.5) 87 (23.7) 0.009 79 (17.2) 53 (26.8) 0.005
Bypass surgery 88 (30.2) 133 (36.2) 0.106 143 (31.1) 78 (39.4) 0.039
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186 Spillerova et al. Annals of Vascular Surgeryscore obtained by nonparsimonious logistic regres-
sion including all variables listed in Table I. Separate
propensity scores were estimated for each defini-
tion. The regression models were calibrated by the
HosmereLemeshow Goodness-of-Fit Test. Model
discrimination was evaluated using the area under
the receiver operating characteristic (ROC) curve.
All tests were two-sided with the alpha level set at
0.05 for statistical significance.Fig. 1. Reintervention rates according to revasculariza-
tion method.RESULTS
After the exclusion criteria, the cohort resulted in a
total of 658 patients, of which 437 (66.4%) were
treated by PTA and 221 (33.6%) by infrapopliteal
surgical bypass. Of 658 patients, 367 (55.8%) ful-
filled the criteria for direct lower limb revasculariza-
tion when definition Awas used.When definition B
was applied, the number of cases who underwent
DR was significantly smaller, 198 (30.1%,
P< 0.05). The baseline and operative characteristics
in patients with DR compared with those with IR ac-
cording to both definitions are summarized in Table
II. Themean follow-upwas 21months (standard de-
viation 13.8 months, range 0e51). In the endovas-
cular group, 29.9% of patients underwent
reintervention compared with 16.7% in bypass sur-
gery (Fig. 1). Two hundred three (30.9%) patientsunderwent minor amputation (130 toe and 73
metatarsal amputations) during the follow-up. It is
worth noting that DR according to definition A
resulted in a rather balanced distribution of baseline
characteristics.When examining definition A of DR,
the patients were significantly younger and a higher
proportion of them had a complete pedal arch
visible at angiography, but they also had a signifi-
cantly higher prevalence of dialysis and foot
gangrene than patients who underwent IR (Table
II). In contrast, patients who underwent DR accord-
ing to definition B were also significantly younger
and had a lower prevalence of atrial fibrillation, a
lower number of affected angiosomes, a higher
prevalence of a complete pedal arch at angiography,
Table III. Propensity-score-adjusted outcome according to 2 different definitions of direct
revascularization
Outcome end points
Definition A Definition B
P value HR (95% CI) P value HR (95% CI)
Wound healing 0.044 1.291 (1.007e1.656) 0.029 1.321 (1.029e1.695)
Major amputation 0.047 0.706 (0.501e0.996) 0.096 0.697 (0.456e1.066)
Mortality 0.938 0.990 (0.761e1.286) 0.087 0.764 (0.561e1.040)
Table IV. Outcome end points adjusted for diabetes, estimated glomerular filtration rate, C-reactive
protein, revascularization method, number of affected angiosomes, and presence of intact pedal arch
according to 2 different definitions of direct revascularization
Outcome end points
Definition A Definition B
P value HR (95% CI) P value HR (95% CI)
Wound healing 0.037 1.294 (1.016e1.648) 0.060 1.267 (0.990e1.621)
Major amputation 0.044 0.703 (0.847e0.990) 0.045 0.652 (0.429e0.990)
Mortality 0.356 0.886 (0.685e1.146) 0.043 0.733 (0.543e0.991)
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however, they had a higher prevalence of dialysis
than their counterparts who underwent IR.
Unadjusted actuarial analysis showed that, irre-
spective of the definition (A or B) that was used,
DR yielded better wound healing and leg salvage
rates when compared with IR: if definition A was
applied, the wound healing rates in the DR versus
IR groups at 1 year were 72.3% vs. 66.6% (log-
rank: P ¼ 0.031), respectively, and the leg salvage
rates at 1 year were 83.4% vs. 75.6% (P ¼ 0.019),
respectively. If definition B was applied, the respec-
tive wound healing rates at 1 year were 74.9% vs.
67.3% (log-rank: P ¼ 0.019) and the respective leg
salvage rates at 1 year were 87.4% vs. 76.8%
(P ¼ 0.003).
A logistic regression model including all variables
listed in Table II provided a propensity score for defi-
nition A of DR (HosmereLemeshow test: P¼ 0.183)
with an area under the ROC curve of 0.635 (95%
confidence interval [CI] 0.593e0.677) and for defi-
nition B a propensity score (HosmereLemeshow
test: P ¼ 0.659) with an area under the ROC curve
of 0.686 (95% CI 0.643e0.729).
A propensity-score-adjusted analysis showed
that, when definition A was adopted, DR was asso-
ciated with significantly better wound healing and
leg salvage rates, whereas when definition B was
applied, DR was associated only with significantly
better wound healing (Table III).
The prognostic ability of definition A was
confirmed in a Cox proportional hazard analysisas adjusted for diabetes, eGFR, C-reactive protein,
revascularization method, number of affected
angiosomes, and the presence of an intact pedal
arch (Table IV). This model also showed a signifi-
cant predictive value of DR according to definition
B for leg salvage and mortality, but only a trend
toward better wound healing. When both DR def-
initions were included in the latter regression
model, only definition A was associated with bet-
ter wound healing (P ¼ 0.040, hazard ratio [HR]
1.286, 95% CI 1.012e1.635) and a lower risk of
major amputation (P ¼ 0.038, HR 0.698, 95% CI
0.497e0.980).DISCUSSION
Even though 2 recent meta-analyses4,5 show a ten-
dency toward better clinical outcome after
angiosome-guided revascularization, many clini-
cians argue against the concept. In our recent study,
we demonstrated that, in only 24% of the patients
with CLI and tissue loss, the wound is limited to
one angiosome and that, in the majority of cases, 2
or more angiosomes are affected.13 Furthermore,
we have shown that the number of affected angio-
somes is associated with wound healing time and
inversely associated with wound healing rate.6
The majority of the studies does not report the
number of affected angiosomes nor define the DR
in cases where the wound affects several angiosom-
es.3,8e11,18e20 The study by Iida et al.16,17 targeted
188 Spillerova et al. Annals of Vascular Surgerythe largest surface affected; due to the dual blood
supply of the heel and digits, however, it is difficult
to correctly define the DR of this regions.
In this study, we included an extensive series of
patients who had lesions affecting more than one
angiosome and in whom 2 different definitions of
angiosome-targeted revascularization, as described
in the methodology, were tested.
Although both definitions were associated with
better wound healing, definition A also seemed to
predict leg salvage when the risk factors were
adjusted with propensity score analysis. Further-
more, the use of definition Bwas less successful clin-
ically as it resulted in fewer cases in which DR was
performed, 30% vs. 56% when definition A was
used. This significant difference may be explained
by the poorer feasibility of an angiosome-targeted
procedure using definition B, as the clinician is
limited to the posterior tibial artery as the only op-
tion for DR in cases where the wound is located in
the forefoot or heel. Furthermore, we experience
that the arteria tibialis posterior was in many cases
severely diseased with long occlusions or multiple
(pearl-like) lesions, therefore the easier artery was
chosen for endovascular treatment.
It is worth noting that the patients in the targeted
revascularization group were divided in terms of
their characteristics when definition A was
compared with definition B. Patients for whom DR
was achieved according to definition B had fewer
comorbidities and less severe foot lesions as graded
by the number of affected angiosomes, in addition
to having lower baseline levels of C-reactive protein
when compared with the patients treated with DR
according to definition A.
While the study by Higashimori et al.21 demon-
strates that an existing intact pedal arch is essential
when only one vessel runoff can be established to
the foot, another study by Rashid et al.22 also sug-
gests that the quality of the pedal arch is more
important with regard to wound healing time than
whether or not angiosome-guided revascularization
is achieved. In this study, we evaluated the intact-
ness of the pedal arch and found that patients with
DR more often had an open pedal arch. However,
this factor was adjusted with propensity score anal-
ysis and should not have an impact on the results.
To confirm the finding of the propensity score
analysis, a Cox proportional hazards model was uti-
lized. This multivariate analysis confirmed the
finding with regard to definition A. In the Cox
model, definition B also predicted leg salvage, but
yielded only a trend toward better wound healing.
The Coxmodel supports the superiority of definition
A with regard to the angiosome concept.Based on our findings, it seems that, if the wound
spreads over more than one angiosome in the loca-
tion of the forefoot or heel, any angiosomal artery
involved in the wound can be targeted to achieve
a better clinical outcome. Therefore, the clinician
has more options to choose from, with a higher
probability that revascularization will be possible
in one of the arteries.
This is a retrospective study, and its main limita-
tion is the description of wound location, which is
extracted from case records. Even though wound
location has been carefully reported in our institu-
tion ever since the emergence of interest in angio-
somes and wound location in the literature,
determination of the affected angiosome canbe diffi-
cult in some cases. Furthermore, the study by Varela
et al.4 showed the importance of collaterals in
wound healing; they concluded that IR via collateral
with good diameter can provide similar result as DR.
This cohort, however, does not provide the informa-
tion of collateralization and therefore it is a limita-
tion to our study as it could influence our results.
Furthermore, in cases where graft occluded
shortly after bypass surgery (n ¼ 15) the wound
was considered nonhealed in follow-up as reproce-
dure or major amputation was performed. Unsuc-
cessful wound healing, however, was related to
surgical failure rather than angiosome-guided
revascularization.
The research on angiosome concept lacks a
well-planned prospective study inwhich thewound
location and size are defined precisely and where
high-quality angiogramswith information on collat-
erals as well as the patency of the pedal arch are per-
formed and thewound healing is followed carefully.
This kind of studywould yield definitive information
on the true influence of angiosome-targeted revas-
cularization on leg salvage. The evidence so far,
although based almost solely on retrospective
reports and therefore not definitive, should guide in-
terventionists toward the direction of angiosome-
targeted revascularization when CLI patients with
tissue lesions are treated.CONCLUSION
Consensus needs to be achieved regarding the accu-
rate definition of DR, especially if more than one
angiosome is clinically involved. In this series, the
proportion of patients meeting the criteria of DR us-
ing definition A was larger than when definition B
was used. Definition A of DR was associated with a
significantly higher wound healing and leg salvage
rate than IR, and its prognostic significance was
Volume 40, April 2017 Infrapopliteal angiosome-targeted revascularization 189not inferior to definition B. Based on our findings, it
seems that, if the wound spreads over more than
one angiosome in the location of the forefoot or
heel, any angiosome involved in the wound can
be targeted to achieve a better clinical outcome.
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